Publications 2025

Andresen S, Al Outa A, Formica M, Enserink J, Knævelsrud H (2025)
Improved detection of lipidated Atg8a by immunoblotting in Drosophila melanogaster cells and tissues enables precise investigation of Atg8a flux and its termination
21 (11), 2497-2517
DOI 10.1080/15548627.2025.2508551, PubMed 40426043

Corrales J, Ramos-Alonso L, González-Sabín J, Ríos-Lombardía N, Trevijano-Contador N, Engen Berg H, Skottvoll FS, Moris F, Zaragoza O, Chymkowitch P, Garcia I, Enserink JM (2025)
Correction for Corrales et al., "Characterization of a selective, iron-chelating antifungal compound that disrupts fungal metabolism and synergizes with fluconazole"
e0073025 (in press)
DOI 10.1128/spectrum.00730-25, PubMed 41117562

Publications 2024

Caulier B, Joaquina S, Gelebart P, Dowling TH, Kaveh F, Thomas M, Tandaric L, Wernhoff P, Katyayini NU, Wogsland C, Gjerstad ME, Fløisand Y, Kvalheim G, Marr C, Kobold S, Enserink JM, Gjertsen BT, McCormack E, Inderberg EM, Wälchli S (2024)
CD37 is a safe chimeric antigen receptor target to treat acute myeloid leukemia
5 (6), 101572
DOI 10.1016/j.xcrm.2024.101572, PubMed 38754420

Corrales J, Ramos-Alonso L, González-Sabín J, Ríos-Lombardía N, Trevijano-Contador N, Engen Berg H, Sved Skottvoll F, Moris F, Zaragoza O, Chymkowitch P, Garcia I, Enserink JM (2024)
Characterization of a selective, iron-chelating antifungal compound that disrupts fungal metabolism and synergizes with fluconazole
12 (2), e0259423
DOI 10.1128/spectrum.02594-23, PubMed 38230926

Fuentes-Martín R, Ayuda-Durán P, Hanes R, Gallego-Yerga L, Wolterinck L, Enserink JM, Álvarez R, Peláez R (2024)
Promising anti-proliferative indolic benzenesulfonamides alter mechanisms with sulfonamide nitrogen substituents
275, 116617
DOI 10.1016/j.ejmech.2024.116617, PubMed 38959729

Wu C, Gunnarsson EB, Myklebust EM, Köhn-Luque A, Tadele DS, Enserink JM, Frigessi A, Foo J, Leder K (2024)
Using birth-death processes to infer tumor subpopulation structure from live-cell imaging drug screening data
20 (3), e1011888
DOI 10.1371/journal.pcbi.1011888, PubMed 38446830

Publications 2023

Al Outa A, Hicks S, Thambawita V, Andresen S, Enserink JM, Halvorsen P, Riegler MA, Knævelsrud H (2023)
CELLULAR, A Cell Autophagy Imaging Dataset
10 (1), 806
DOI 10.1038/s41597-023-02687-x, PubMed 37973836

Andersen AN, Brodersen AM, Ayuda-Durán P, Piechaczyk L, Tadele DS, Baken L, Fredriksen J, Stoksflod M, Lenartova A, Fløisand Y, Skånland SS, Enserink JM (2023)
Clinical forecasting of acute myeloid leukemia using ex vivo drug-sensitivity profiling
3 (12), 100654
DOI 10.1016/j.crmeth.2023.100654, PubMed 38065095

Ayuda-Durán P, Hermansen JU, Giliberto M, Yin Y, Hanes R, Gordon S, Kuusanmäki H, Brodersen AM, Andersen AN, Taskén K, Wennerberg K, Enserink JM, Skånland SS (2023)
Standardized assays to monitor drug sensitivity in hematologic cancers
9 (1), 435
DOI 10.1038/s41420-023-01722-5, PubMed 38040674

Chen Y, He L, Ianevski A, Ayuda-Durán P, Potdar S, Saarela J, Miettinen JJ, Kytölä S, Miettinen S, Manninen M, Heckman CA, Enserink JM, Wennerberg K, Aittokallio T (2023)
Robust scoring of selective drug responses for patient-tailored therapy selection
19 (1), 60-82
DOI 10.1038/s41596-023-00903-x, PubMed 37996540

Hanes R, Ayuda-Durán P, Rønneberg L, Nakken S, Hovig E, Zucknick M, Enserink JM (2023)
screenwerk: a modular tool for the design and analysis of drug combination screens
39 (1)
DOI 10.1093/bioinformatics/btac840, PubMed 36573326

Johannessen JA, Formica M, Haukeland ALC, Bråthen NR, Al Outa A, Aarsund M, Therrien M, Enserink JM, Knævelsrud H (2023)
The human leukemic oncogene MLL-AF4 promotes hyperplastic growth of hematopoietic tissues in Drosophila larvae
26 (10), 107726
DOI 10.1016/j.isci.2023.107726, PubMed 37720104

Köhn-Luque A, Myklebust EM, Tadele DS, Giliberto M, Schmiester L, Noory J, Harivel E, Arsenteva P, Mumenthaler SM, Schjesvold F, Taskén K, Enserink JM, Leder K, Frigessi A, Foo J (2023)
Phenotypic deconvolution in heterogeneous cancer cell populations using drug-screening data
3 (3), 100417
DOI 10.1016/j.crmeth.2023.100417, PubMed 37056380

Ramos-Alonso L, Holland P, Le Gras S, Zhao X, Jost B, Bjørås M, Barral Y, Enserink JM, Chymkowitch P (2023)
Mitotic chromosome condensation resets chromatin to safeguard transcriptional homeostasis during interphase
120 (4), e2210593120
DOI 10.1073/pnas.2210593120, PubMed 36656860

Tislevoll BS, Hellesøy M, Fagerholt OHE, Gullaksen SE, Srivastava A, Birkeland E, Kleftogiannis D, Ayuda-Durán P, Piechaczyk L, Tadele DS, Skavland J, Baliakas P, Hovland R, Andresen V, Seternes OM, Tvedt THA, Aghaeepour N, Gavasso S, Porkka K, Jonassen I, Fløisand Y, Enserink J, Blaser N, Gjertsen BT (2023)
Early response evaluation by single cell signaling profiling in acute myeloid leukemia
14 (1), 115
DOI 10.1038/s41467-022-35624-4, PubMed 36611026

Tislevoll BS, Hellesøy M, Fagerholt OHE, Gullaksen SE, Srivastava A, Birkeland E, Kleftogiannis D, Ayuda-Durán P, Piechaczyk L, Tadele DS, Skavland J, Baliakas P, Hovland R, Andresen V, Seternes OM, Tvedt THA, Aghaeepour N, Gavasso S, Porkka K, Jonassen I, Fløisand Y, Enserink J, Blaser N, Gjertsen BT (2023)
Author Correction: Early response evaluation by single cell signaling profiling in acute myeloid leukemia
14 (1), 1767
DOI 10.1038/s41467-023-37488-8, PubMed 36997540

Publications 2022

Enserink JM (2022)
The SUMO stress response in transcriptional regulation: Causal relationships or secondary bystander effects?
44 (7), e2200065
DOI 10.1002/bies.202200065, PubMed 35655365

Enserink JM, Chymkowitch P (2022)
Cell Cycle-Dependent Transcription: The Cyclin Dependent Kinase Cdk1 Is a Direct Regulator of Basal Transcription Machineries
23 (3)
DOI 10.3390/ijms23031293, PubMed 35163213

Ramos-Alonso L, Garcia I, Enserink JM, Chymkowitch P (2022)
Analysis of the pheromone signaling pathway by RT-qPCR in the budding yeast Saccharomyces cerevisiae
3 (1), 101210
DOI 10.1016/j.xpro.2022.101210, PubMed 35265859

Zhao X, Hendriks IA, Le Gras S, Ye T, Ramos-Alonso L, Nguéa P A, Lien GF, Ghasemi F, Klungland A, Jost B, Enserink JM, Nielsen ML, Chymkowitch P (2022)
Waves of sumoylation support transcription dynamics during adipocyte differentiation
50 (3), 1351-1369
DOI 10.1093/nar/gkac027, PubMed 35100417

Publications 2021

Caulier B, Enserink JM, Wälchli S (2021)
Pharmacologic Control of CAR T Cells
22 (9)
DOI 10.3390/ijms22094320, PubMed 33919245

Garcia I, Orellana-Muñoz S, Ramos-Alonso L, Andersen AN, Zimmermann C, Eriksson J, Bøe SO, Kaferle P, Papamichos-Chronakis M, Chymkowitch P, Enserink JM (2021)
Kel1 is a phosphorylation-regulated noise suppressor of the pheromone signaling pathway
37 (13), 110186
DOI 10.1016/j.celrep.2021.110186, PubMed 34965431

Grad I, Hanes R, Ayuda-Durán P, Kuijjer ML, Enserink JM, Meza-Zepeda LA, Myklebost O (2021)
Discovery of novel candidates for anti-liposarcoma therapies by medium-scale high-throughput drug screening
16 (3), e0248140
DOI 10.1371/journal.pone.0248140, PubMed 33690666

Klionsky DJ, Abdel-Aziz AK, Abdelfatah S, Abdellatif M, Abdoli A, Abel S, Abeliovich H, Abildgaard MH, Abudu YP, Acevedo-Arozena A, Adamopoulos IE, Adeli K, Adolph TE, Adornetto A, Aflaki E, Agam G, Agarwal A, Aggarwal BB, Agnello M, Agostinis P, Agrewala JN, Agrotis A, Aguilar PV, Ahmad ST, Ahmed ZM et al. (2021)
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)¹
17 (1), 1-382
DOI 10.1080/15548627.2020.1797280, PubMed 33634751

Melvold K, Giliberto M, Karlsen L, Ayuda-Durán P, Hanes R, Holien T, Enserink J, Brown JR, Tjønnfjord GE, Taskén K, Skånland SS (2021)
Mcl-1 and Bcl-xL levels predict responsiveness to dual MEK/Bcl-2 inhibition in B-cell malignancies
16 (5), 1153-1170
DOI 10.1002/1878-0261.13153, PubMed 34861096

Rønneberg L, Cremaschi A, Hanes R, Enserink JM, Zucknick M (2021)
bayesynergy: flexible Bayesian modelling of synergistic interaction effects in in vitro drug combination experiments
22 (6)
DOI 10.1093/bib/bbab251, PubMed 34308471

Publications 2020

Omsland M, Andresen V, Gullaksen SE, Ayuda-Durán P, Popa M, Hovland R, Brendehaug A, Enserink J, McCormack E, Gjertsen BT (2020)
Tyrosine kinase inhibitors and interferon-α increase tunneling nanotube (TNT) formation and cell adhesion in chronic myeloid leukemia (CML) cell lines
34 (3), 3773-3791
DOI 10.1096/fj.201802061RR, PubMed 31945226

Tadele DS, Robertson J, Crispin R, Herrera MC, Chlubnová M, Piechaczyk L, Ayuda-Durán P, Singh SK, Gedde-Dahl T, Fløisand Y, Skavland J, Wesche J, Gjertsen BT, Enserink JM (2020)
A cell competition-based small molecule screen identifies a novel compound that induces dual c-Myc depletion and p53 activation
296, 100179
DOI 10.1074/jbc.RA120.015285, PubMed 33303632

Publications 2019

Nguéa P A, Robertson J, Herrera MC, Chymkowitch P, Enserink JM (2019)
Desumoylation of RNA polymerase III lies at the core of the Sumo stress response in yeast
294 (49), 18784-18795
DOI 10.1074/jbc.RA119.009721, PubMed 31676685

Prikrylova T, Robertson J, Ferrucci F, Konorska D, Aanes H, Manaf A, Zhang B, Vågbø CB, Kuśnierczyk A, Gilljam KM, Løvkvam-Køster C, Otterlei M, Dahl JA, Enserink J, Klungland A, Robertson AB (2019)
5-hydroxymethylcytosine Marks Mammalian Origins Acting as a Barrier to Replication
9 (1), 11065
DOI 10.1038/s41598-019-47528-3, PubMed 31363131

Zhang B, Ayuda-Durán P, Piechaczyk L, Fløisand Y, Safont MM, Karlsen IT, Fandalyuk Z, Tadele D, van Mierlo P, Rowe AD, Robertson JM, Gjertsen BT, McCormack E, Enserink JM (2019)
GRP94 rewires and buffers the FLT3-ITD signaling network and promotes survival of acute myeloid leukemic stem cells
104 (5), e229
DOI 10.3324/haematol.2019.220533, PubMed 31040234

Publications 2018

Herrera MC, Chymkowitch P, Robertson JM, Eriksson J, Bøe SO, Alseth I, Enserink JM (2018)
Cdk1 gates cell cycle-dependent tRNA synthesis by regulating RNA polymerase III activity
46 (22), 11698-11711
DOI 10.1093/nar/gky846, PubMed 30247619

Herrera MC, Chymkowitch P, Robertson JM, Eriksson J, Bøe SO, Alseth I, Enserink JM (2018)
Corrigendum: Cdk1 gates cell cycle-dependent tRNA synthesis by regulating RNA polymerase III activity
46 (22), 12188-12189
DOI 10.1093/nar/gky1102, PubMed 30395271

Kruitwagen T, Chymkowitch P, Denoth-Lippuner A, Enserink J, Barral Y (2018)
Centromeres License the Mitotic Condensation of Yeast Chromosome Arms
175 (3), 780-795.e15
DOI 10.1016/j.cell.2018.09.012, PubMed 30318142

Zhang B, Durán PA, Piechaczyk L, Fløisand Y, Safont MMS, Karlsen IT, Fandalyuk Z, Tadele D, Mierlo PV, Rowe AD, Robertson JM, Gjertsen BT, McCormack E, Enserink JM, Bjørn Tore Gjertsen Group, Emmet McCormack Group (2018)
GRP94 rewires and buffers the FLT3-ITD signaling network and promotes survival of acute myeloid leukemic stem cells
Online ahead of print (in press) (Retracted)
DOI 10.3324/haematol.2018.189399, PubMed 29748445

Publications 2017

Chymkowitch P, Enserink JM (2017)
Regulation of tRNA synthesis by posttranslational modifications of RNA polymerase III subunits
1861 (4), 310-319
DOI 10.1016/j.bbagrm.2017.11.001, PubMed 29127063

Chymkowitch P, Nguéa P A, Aanes H, Robertson J, Klungland A, Enserink JM (2017)
TORC1-dependent sumoylation of Rpc82 promotes RNA polymerase III assembly and activity
114 (5), 1039-1044
DOI 10.1073/pnas.1615093114, PubMed 28096404

Chymkowitch P, P AN, Aanes H, Koehler CJ, Thiede B, Lorenz S, Meza-Zepeda LA, Klungland A, Enserink JM (2017)
Corrigendum: Sumoylation of Rap1 mediates the recruitment of TFIID to promote transcription of ribosomal protein genes
27 (2), 334
DOI 10.1101/gr.218370.116, PubMed 28148563

Enserink J, Nguéa P A, Chymkowitch P (2017)
Anabolic transcription: Secrets of the sumo diet
16 (7), 593-594
DOI 10.1080/15384101.2017.1294945, PubMed 28278057

Enserink JM (2017)
Regulation of Cellular Processes by SUMO: Understudied Topics
963, 89-97
DOI 10.1007/978-3-319-50044-7_5, PubMed 28197907

Enserink JM (2017)
Sumo during stress: When transcription takes a pause (comment on DOI.10.1002/bies.201600263)
39 (6)
DOI 10.1002/bies.201700065, PubMed 28464310

Pietarinen PO, Eide CA, Ayuda-Durán P, Potdar S, Kuusanmäki H, Andersson EI, Mpindi JP, Pemovska T, Kontro M, Heckman CA, Kallioniemi O, Wennerberg K, Hjorth-Hansen H, Druker BJ, Enserink JM, Tyner JW, Mustjoki S, Porkka K (2017)
Differentiation status of primary chronic myeloid leukemia cells affects sensitivity to BCR-ABL1 inhibitors
8 (14), 22606-22615
DOI 10.18632/oncotarget.15146, PubMed 28186983

Zimmermann C, Garcia I, Omerzu M, Chymkowitch P, Zhang B, Enserink JM (2017)
Mapping the Synthetic Dosage Lethality Network of CDK1/CDC28
7 (6), 1753-1766
DOI 10.1534/g3.117.042317, PubMed 28428242

Zimmermann C, Santos A, Gable K, Epstein S, Gururaj C, Chymkowitch P, Pultz D, Rødkær SV, Clay L, Bjørås M, Barral Y, Chang A, Færgeman NJ, Dunn TM, Riezman H, Enserink JM (2017)
TORC1 Inhibits GSK3-Mediated Elo2 Phosphorylation to Regulate Very Long Chain Fatty Acid Synthesis and Autophagy
18 (8), 2073-2074
DOI 10.1016/j.celrep.2017.02.020, PubMed 28228270

Publications 2016

Klionsky DJ, Abdelmohsen K, Abe A, Abedin MJ, Abeliovich H, Acevedo Arozena A, Adachi H, Adams CM, Adams PD, Adeli K, Adhihetty PJ, Adler SG, Agam G, Agarwal R, Aghi MK, Agnello M, Agostinis P, Aguilar PV, Aguirre-Ghiso J, Airoldi EM, Ait-Si-Ali S, Akematsu T, Akporiaye ET, Al-Rubeai M, Albaiceta GM et al. (2016)
Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)
12 (1), 1-222
DOI 10.1080/15548627.2015.1100356, PubMed 26799652

Publications 2015

Chymkowitch P, Nguéa P A, Enserink JM (2015)
SUMO-regulated transcription: challenging the dogma
37 (10), 1095-105
DOI 10.1002/bies.201500065, PubMed 26354225

Chymkowitch P, Nguéa AP, Aanes H, Koehler CJ, Thiede B, Lorenz S, Meza-Zepeda LA, Klungland A, Enserink JM (2015)
Sumoylation of Rap1 mediates the recruitment of TFIID to promote transcription of ribosomal protein genes
25 (6), 897-906
DOI 10.1101/gr.185793.114, PubMed 25800674

Enserink JM (2015)
Sumo and the cellular stress response
10, 4
DOI 10.1186/s13008-015-0010-1, PubMed 26101541

Publications 2014

Davydova E, Ho AYY, Malecki J, Moen A, Enserink JM, Jakobsson ME, Loenarz C, Falnes PØ (2014)
Identification and characterization of a novel evolutionarily conserved lysine-specific methyltransferase targeting eukaryotic translation elongation factor 2 (eEF2)
289 (44), 30499-30510
DOI 10.1074/jbc.M114.601658, PubMed 25231979

Enserink JM (2014)
Metabolic pathways further increase the complexity of cell size control in budding yeast
1 (9), 276-278
DOI 10.15698/mic2014.09.167, PubMed 28362005

Publications 2013

Zimmermann C, Santos A, Gable K, Epstein S, Gururaj C, Chymkowitch P, Pultz D, Rødkær SV, Clay L, Bjørås M, Barral Y, Chang A, Færgeman NJ, Dunn TM, Riezman H, Enserink JM (2013)
TORC1 inhibits GSK3-mediated Elo2 phosphorylation to regulate very long chain fatty acid synthesis and autophagy
5 (4), 1036-46
DOI 10.1016/j.celrep.2013.10.024, PubMed 24239358

Publications 2012

Chymkowitch P, Eldholm V, Lorenz S, Zimmermann C, Lindvall JM, Bjørås M, Meza-Zepeda LA, Enserink JM (2012)
Cdc28 kinase activity regulates the basal transcription machinery at a subset of genes
109 (26), 10450-5
DOI 10.1073/pnas.1200067109, PubMed 22689984

Chymkowitch P, Enserink JM (2012)
The cell cycle rallies the transcription cycle: Cdc28/Cdk1 is a cell cycle-regulated transcriptional CDK
4 (1), 3-6
DOI 10.4161/trns.22456, PubMed 23131667

Enserink JM (2012)
Chemical genetics: budding yeast as a platform for drug discovery and mapping of genetic pathways
17 (8), 9258-73
DOI 10.3390/molecules17089258, PubMed 22858845

Enserink JM, Kolodner RD (2012)
What makes the engine hum: Rad6, a cell cycle supercharger
11 (2), 249-52
DOI 10.4161/cc.11.2.19023, PubMed 22214660

Pultz D, Bennetzen MV, Rødkær SV, Zimmermann C, Enserink JM, Andersen JS, Færgeman NJ (2012)
Global mapping of protein phosphorylation events identifies Ste20, Sch9 and the cell-cycle regulatory kinases Cdc28/Pho85 as mediators of fatty acid starvation responses in Saccharomyces cerevisiae
8 (3), 796-803
DOI 10.1039/c2mb05356j, PubMed 22218487

Publications 2011

Zimmermann C, Chymkowitch P, Eldholm V, Putnam CD, Lindvall JM, Omerzu M, Bjørås M, Kolodner RD, Enserink JM (2011)
A chemical-genetic screen to unravel the genetic network of CDC28/CDK1 links ubiquitin and Rad6-Bre1 to cell cycle progression
108 (46), 18748-53
DOI 10.1073/pnas.1115885108, PubMed 22042866

Publications 2010

Enserink JM, Kolodner RD (2010)
An overview of Cdk1-controlled targets and processes
5, 11
DOI 10.1186/1747-1028-5-11, PubMed 20465793

Publications 2009

Enserink JM, Hombauer H, Huang ME, Kolodner RD (2009)
Cdc28/Cdk1 positively and negatively affects genome stability in S. cerevisiae
185 (3), 423-37
DOI 10.1083/jcb.200811083, PubMed 19398760

Kats ES, Enserink JM, Martinez S, Kolodner RD (2009)
The Saccharomyces cerevisiae Rad6 postreplication repair and Siz1/Srs2 homologous recombination-inhibiting pathways process DNA damage that arises in asf1 mutants
29 (19), 5226-37
DOI 10.1128/MCB.00894-09, PubMed 19635810

Publications 2006

Bryn T, Mahic M, Enserink JM, Schwede F, Aandahl EM, Taskén K (2006)
The cyclic AMP-Epac1-Rap1 pathway is dissociated from regulation of effector functions in monocytes but acquires immunoregulatory function in mature macrophages
176 (12), 7361-70
DOI 10.4049/jimmunol.176.12.7361, PubMed 16751380

Enserink JM, Smolka MB, Zhou H, Kolodner RD (2006)
Checkpoint proteins control morphogenetic events during DNA replication stress in Saccharomyces cerevisiae
175 (5), 729-41
DOI 10.1083/jcb.200605080, PubMed 17130284

Smolka MB, Chen SH, Maddox PS, Enserink JM, Albuquerque CP, Wei XX, Desai A, Kolodner RD, Zhou H (2006)
An FHA domain-mediated protein interaction network of Rad53 reveals its role in polarized cell growth
175 (5), 743-53
DOI 10.1083/jcb.200605081, PubMed 17130285

Publications 2004

Enserink JM, Price LS, Methi T, Mahic M, Sonnenberg A, Bos JL, Taskén K (2004)
The cAMP-Epac-Rap1 pathway regulates cell spreading and cell adhesion to laminin-5 through the alpha3beta1 integrin but not the alpha6beta4 integrin
279 (43), 44889-96
DOI 10.1074/jbc.M404599200, PubMed 15302884

Johansson CC, Yndestad A, Enserink JM, Ree AH, Aukrust P, Taskén K (2004)
The epidermal growth factor-like growth factor amphiregulin is strongly induced by the adenosine 3',5'-monophosphate pathway in various cell types
145 (11), 5177-84
DOI 10.1210/en.2004-0232, PubMed 15284208

Vang T, Abrahamsen H, Myklebust S, Enserink J, Prydz H, Mustelin T, Amarzguioui M, Tasken K (2004)
Knockdown of C-terminal Src kinase by siRNA-mediated RNA interference augments T cell receptor signaling in mature T cells
34 (8), 2191-9
DOI 10.1002/eji.200425036, PubMed 15259016

Publications 2003

Bos JL, de Bruyn K, Enserink J, Kuiperij B, Rangarajan S, Rehmann H, Riedl J, de Rooij J, van Mansfeld F, Zwartkruis F (2003)
The role of Rap1 in integrin-mediated cell adhesion
31 (Pt 1), 83-6
DOI 10.1042/bst0310083, PubMed 12546659

Rangarajan S, Enserink JM, Kuiperij HB, de Rooij J, Price LS, Schwede F, Bos JL (2003)
Cyclic AMP induces integrin-mediated cell adhesion through Epac and Rap1 upon stimulation of the beta 2-adrenergic receptor
160 (4), 487-93
DOI 10.1083/jcb.200209105, PubMed 12578910

Publications 2002

Enserink JM, Christensen AE, de Rooij J, van Triest M, Schwede F, Genieser HG, Døskeland SO, Blank JL, Bos JL (2002)
A novel Epac-specific cAMP analogue demonstrates independent regulation of Rap1 and ERK
4 (11), 901-6
DOI 10.1038/ncb874, PubMed 12402047

Verschure PJ, Van Der Kraan I, Enserink JM, Moné MJ, Manders EM, Van Driel R (2002)
Large-scale chromatin organization and the localization of proteins involved in gene expression in human cells
50 (10), 1303-12
DOI 10.1177/002215540205001003, PubMed 12364563

Publications 2000

Staal A, Enserink JM, Stein JL, Stein GS, van Wijnen AJ (2000)
Molecular characterization of celtix-1, a bromodomain protein interacting with the transcription factor interferon regulatory factor 2
185 (2), 269-79
DOI 10.1002/1097-4652(200011)185:2<269::AID-JCP12>3.0.CO;2-L, PubMed 11025449